Tokyo Tape
Sign in
← Sumitomo Pharma

Quarterly report · Q2

4506.TEDINET S100S3MQ
Period2023-04-01 → 2023-09-30
Filed2023-11-02
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 56
MetricValuePeriodScopeSource row
Revenue¥152.6bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Revenue¥77.0bn2023-07-01 → 2023-09-30dCons.Revenue IFRS
Revenue¥555.5bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥319.3bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥159.4bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Operating income−¥86.5bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥34.9bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income−¥28.9bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥43.5bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax−¥56.1bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥25.1bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax−¥47.9bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥21.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥25.6bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)−¥67.7bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥28.9bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥74.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥7.3bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥38.4bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥67.7bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥28.9bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income−¥15.2bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥43.3bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥1.15Tat 2023-09-30Cons.Assets IFRS
Total assets¥1.13Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.41Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥736.8bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥728.0bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥412.0bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥406.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥718.6bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥673.6bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥412.0bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥406.7bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥646.1bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥60.4bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥143.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥250.6bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥203.0bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥174.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥11.9bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥29.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥32.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥52.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥7.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥44.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥146.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥26.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-170.512023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-72.682023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-187.552022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-18.332022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-96.632022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
Equity ratio35.9%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio35.8%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.9%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
jpcrp040300-q2r_E00922-000Asiareportable segmentrevenue external2023-04-01 → 2023-09-30¥20.8bn
jpcrp040300-q2r_E00922-000Asiareportable segmentrevenue external2023-07-01 → 2023-09-30¥11.0bn
jpcrp040300-q2r_E00922-000Asiareportable segmentsegment profit2023-04-01 → 2023-09-30¥9.9bn
jpcrp040300-q2r_E00922-000Asiareportable segmentsegment profit2023-07-01 → 2023-09-30¥5.6bn
jpcrp040300-q2r_E00922-000Japanreportable segmentrevenue external2023-04-01 → 2023-09-30¥58.5bn
jpcrp040300-q2r_E00922-000Japanreportable segmentrevenue external2023-07-01 → 2023-09-30¥28.2bn
jpcrp040300-q2r_E00922-000Japanreportable segmentsegment profit2023-04-01 → 2023-09-30¥5.9bn
jpcrp040300-q2r_E00922-000Japanreportable segmentsegment profit2023-07-01 → 2023-09-30¥3.0bn
jpcrp040300-q2r_E00922-000North Americareportable segmentrevenue external2023-04-01 → 2023-09-30¥73.3bn
jpcrp040300-q2r_E00922-000North Americareportable segmentrevenue external2023-07-01 → 2023-09-30¥37.8bn
jpcrp040300-q2r_E00922-000North Americareportable segmentsegment profit2023-04-01 → 2023-09-30−¥42.2bn
jpcrp040300-q2r_E00922-000North Americareportable segmentsegment profit2023-07-01 → 2023-09-30−¥18.4bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥152.6bn
—segment totalrevenue external2023-07-01 → 2023-09-30¥77.0bn
—segment totalsegment profit2023-04-01 → 2023-09-30−¥26.4bn
—segment totalsegment profit2023-07-01 → 2023-09-30−¥9.9bn
jpcrp040300-q2r_E00922-000Asiareportable segmentrevenue external2022-04-01 → 2022-09-30¥25.9bn
jpcrp040300-q2r_E00922-000Asiareportable segmentrevenue external2022-07-01 → 2022-09-30¥13.2bn
jpcrp040300-q2r_E00922-000Asiareportable segmentsegment profit2022-04-01 → 2022-09-30¥14.0bn
jpcrp040300-q2r_E00922-000Asiareportable segmentsegment profit2022-07-01 → 2022-09-30¥8.2bn
jpcrp040300-q2r_E00922-000Japanreportable segmentrevenue external2022-04-01 → 2022-09-30¥98.1bn
jpcrp040300-q2r_E00922-000Japanreportable segmentrevenue external2022-07-01 → 2022-09-30¥46.0bn
jpcrp040300-q2r_E00922-000Japanreportable segmentsegment profit2022-04-01 → 2022-09-30¥12.9bn
jpcrp040300-q2r_E00922-000Japanreportable segmentsegment profit2022-07-01 → 2022-09-30¥4.1bn
jpcrp040300-q2r_E00922-000North Americareportable segmentrevenue external2022-04-01 → 2022-09-30¥195.3bn
jpcrp040300-q2r_E00922-000North Americareportable segmentrevenue external2022-07-01 → 2022-09-30¥100.2bn
jpcrp040300-q2r_E00922-000North Americareportable segmentsegment profit2022-04-01 → 2022-09-30¥47.3bn
jpcrp040300-q2r_E00922-000North Americareportable segmentsegment profit2022-07-01 → 2022-09-30¥24.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥319.3bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥159.4bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥74.2bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥36.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 800
ItemContextValueUnit
Gross profit IFRSCurrentYTDDuration92319000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration207913000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration134044000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration49980000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration50356000000JPY
Other income IFRSPrior1YTDDuration3178000000JPY
Other income IFRSCurrentYTDDuration6445000000JPY
Other expenses IFRSPrior1YTDDuration648000000JPY
Other expenses IFRSCurrentYTDDuration862000000JPY
Operating profit loss IFRSPrior1YTDDuration-28915000000JPY
Operating profit loss IFRSCurrentYTDDuration-86498000000JPY
Finance income IFRSPrior1YTDDuration51698000000JPY
Finance income IFRSCurrentYTDDuration32022000000JPY
Finance costs IFRSPrior1YTDDuration1749000000JPY
Finance costs IFRSCurrentYTDDuration1651000000JPY
Profit loss before tax IFRSPrior1YTDDuration21034000000JPY
Profit loss before tax IFRSCurrentYTDDuration-56127000000JPY
Income tax expense IFRSPrior1YTDDuration36277000000JPY
Income tax expense IFRSCurrentYTDDuration11609000000JPY
Profit loss IFRSPrior1YTDDuration-15243000000JPY
Profit loss IFRSCurrentYTDDuration-67736000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-7283000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-67741000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration-7960000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration5000000JPY
Profit loss IFRSPrior1YTDDuration-15243000000JPY
Profit loss IFRSCurrentYTDDuration-67736000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-18.33
Basic earnings loss per share IFRSCurrentYTDDuration-170.51
Revenue IFRSPrior1QuarterDuration159413000000JPY
Revenue IFRSCurrentQuarterDuration76956000000JPY
Cost of sales IFRSPrior1QuarterDuration46785000000JPY
Cost of sales IFRSCurrentQuarterDuration29893000000JPY
Gross profit IFRSPrior1QuarterDuration112628000000JPY
Gross profit IFRSCurrentQuarterDuration47063000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration130624000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration59153000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration25558000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration22512000000JPY
Other income IFRSPrior1QuarterDuration390000000JPY
Other income IFRSCurrentQuarterDuration110000000JPY
Other expenses IFRSPrior1QuarterDuration365000000JPY
Other expenses IFRSCurrentQuarterDuration439000000JPY
Operating profit loss IFRSPrior1QuarterDuration-43529000000JPY
Operating profit loss IFRSCurrentQuarterDuration-34931000000JPY
Finance income IFRSPrior1QuarterDuration18819000000JPY
Finance income IFRSCurrentQuarterDuration10707000000JPY
Finance costs IFRSPrior1QuarterDuration866000000JPY
Finance costs IFRSCurrentQuarterDuration851000000JPY
Profit loss before tax IFRSPrior1QuarterDuration-25576000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass